Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Ltd

Health CareHealth Care Equipment & Services
  • Price (NZD)16.55
  • Today's Change0.04 / 0.24%
  • Shares traded251.25k
  • 1 Year change8.52%
  • Beta1.6274
Data delayed at least 20 minutes, as of Sep 13 2019 06:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The Company's segments include New Zealand, which includes all activities controlled by entities or employees based in New Zealand; North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong. Its products include respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warmers and accessories. In addition, the Company offers hardware and consumables.

  • Revenue in NZD (TTM)1.07bn
  • Net income in NZD209.20m
  • Incorporated1954
  • Employees4.55k
  • Location
    Fisher & Paykel Healthcare Corporation Ltd15 Maurice Paykel Place, East TamakiAUCKLAND 1061New ZealandNZL
  • Phone+64 95740100
  • Fax+64 95740158
  • Websitehttps://www.fphcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
China National Medicines Corporation Ltd9.08bn337.31m4.84bn2.86k14.372.26--0.53331.991.9953.5812.671.9311.924.0714,347,500.008.188.3118.5119.648.307.934.243.881.56--0.134118.596.7730.9023.0127.821.729.00
Hartalega Holdings Berhad1.04bn159.80m6.67bn7.70k41.927.6633.176.410.12570.12570.81820.68840.9566--7.28358,567.1014.6915.8417.1118.24--26.3615.3616.971.7447.000.131153.5417.5220.623.7014.3517.0917.73
Shandong Weigao Group Medical Polymer Co2.13bn390.05m7.83bn9.56k19.892.2814.483.680.43390.43392.373.780.40313.162.401,109,876.007.688.049.319.6962.7461.3419.0419.092.529.110.25731.2139.9913.8117.3430.58-4.7428.11
Fisher & Paykel Healthcare Corp Ltd1.07bn209.20m9.50bn4.55k45.7310.3937.868.870.36190.36191.851.590.95922.717.04235,408.0018.7519.3822.3923.5066.8765.1719.5418.611.73225.710.086365.019.1411.429.9916.6033.1315.63
ASAHI INTECC CO., LTD.830.13m163.04m9.71bn7.00k59.7110.2345.7611.7043.0543.05219.14251.390.73141.365.99--14.3713.9017.1017.0669.3967.1919.6418.562.5241.820.084225.0814.1515.2511.9120.8534.5520.51
Cochlear Limited1.54bn298.44m13.20bn4.00k44.1516.8338.828.584.794.7924.7212.581.131.904.48356,675.0021.8220.8729.3029.7375.8573.1619.3917.821.22--0.200169.814.6212.139.7624.1829.115.37
Data as of Sep 13 2019. Currency figures normalised to Fisher & Paykel Healthcare Corporation Ltd's reporting currency: New Zealand Dollar NZD

Institutional shareholders

22.92%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 13 Dec 201830.15m5.25%
Capital Research & Management Co. (World Investors)as of 30 Jun 201923.97m4.18%
BlackRock Fund Advisorsas of 19 Mar 201918.79m3.27%
Accident Compensation Corp.as of 30 Apr 201813.92m2.43%
Guardians of New Zealand Superannuationas of 30 Jun 201813.90m2.42%
Fidelity Management & Research Co.as of 31 Jul 20199.18m1.60%
T. Rowe Price International Ltd.as of 30 Jun 20196.97m1.21%
Norges Bank Investment Managementas of 31 Dec 20186.41m1.12%
Capital Research & Management Co. (Global Investors)as of 30 Jun 20194.46m0.78%
Australian Foundation Investment Co. Ltd. (Invt Mgmt)as of 30 Jun 20193.81m0.66%
More ▼
Data from 30 Jun 2018 - 31 Jul 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.